David F Ranney

Title: **David F. Ranney: A Pioneer in Genetic Molecular Interaction Systems**

Introduction

David F. Ranney, based in Dallas, Texas, is a distinguished inventor known for his significant contributions to the field of genetic molecular interaction systems. With an impressive portfolio of 12 patents, his innovations predominantly focus on methods for detecting interactions between proteins, enhancing the sensitivity of these detections, and improving drug delivery systems.

Latest Patents

Ranney's most recent patents include groundbreaking technologies in adjustable sensitivity for genetic molecular interactions. One notable invention is a method designed for detecting interactions between two molecules with variable sensitivity. This flexibility is achieved by manipulating hybrid proteins, allowing for overexpression that adjusts the sensitivity of detection depending on the specific needs of the analysis.

Another significant patent introduces a drug carrier composition that incorporates a drug complexed with dermatan sulfate. This composition is not only effective for delivering anti-tumor drugs such as doxorubicin, taxol, and vincristine but also enhances vascular access. The design of the carrier promotes rapid endothelial envelopment and sequestration of the drug, effectively shielding it from early clearance and improving migration efficiency across vascular barriers. This innovative approach can also facilitate drug transport across epithelial membranes, showcasing its potential applications in treating various conditions.

Career Highlights

Throughout his career, David Ranney has made substantial contributions while working with notable companies, including Access Pharmaceuticals, Inc. His work has focused on developing innovative solutions that impact healthcare and improve patient outcomes through better drug delivery and molecular interaction analysis.

Collaborations

Collaboration has been a vital aspect of Ranney's career. He has worked alongside accomplished individuals such as Alfred J. Quattrone and David N. Edwards. These partnerships have helped in advancing his research and bringing innovative solutions to market.

Conclusion

David F. Ranney remains a prominent figure in the field of genetic molecular systems and drug delivery. His innovative patents and collaborative efforts illustrate his dedication to enhancing the efficacy of medical treatments. Through his work, he continues to pave the way for future advancements in biotechnology and healthcare.